Add to ORKGWe evaluated the use of the molecular bacterial load (MBL) assay, for measuring viable Mycobacterium tuberculosis in sputum, in comparison with solid agar and liquid culture. The MBL assay provides early information on the rate of decline in bacterial load and has technical advantages over culture in either form
This work was supported by the commonwealth studentship award for Bariki Mtafya at University of St ...
Bacterial killing in patients with tuberculosis (TB) relapse was compared to that in patients achiev...
Tuberculosis is caused by Mycobacterium tuberculosis (Mtb), a pathogen classified by the United Nati...
We evaluated the use of the molecular bacterial load (MBL) assay, for measuring viable Mycobacterium...
A molecular assay to quantify Mycobacterium tuberculosis is described. In vitro, 98% (n = 96) of spu...
Molecular bacterial load assay (MBLA) rapidly quantifies viable Mycobacterium tuberculosis (Mtb) and...
A molecular assay to quantify Mycobacterium tuberculosis is described. In vitro, 98% (n = 96) of spu...
Tuberculosis is a difficult disease to treat, a process made more harder as tools to monitor treatme...
Tuberculosis is a difficult disease to treat, a process made more harder as tools to monitor treatme...
In this comparative biomarker study, we analysed 1768 serial sputum samples from 178 patients at 4 s...
In this comparative biomarker study, we analysed 1768 serial sputum samples from 178 patients at 4 s...
The molecular bacterial load (MBL) assay is a new tuberculosis biomarker which provides results in ∼...
The lack of rapid, sensitive, and deployable tuberculosis diagnostic tools is hampering the early di...
This work was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP)...
The early bactericidal activity of antituberculosis agents is usually determined by measuring the re...
This work was supported by the commonwealth studentship award for Bariki Mtafya at University of St ...
Bacterial killing in patients with tuberculosis (TB) relapse was compared to that in patients achiev...
Tuberculosis is caused by Mycobacterium tuberculosis (Mtb), a pathogen classified by the United Nati...
We evaluated the use of the molecular bacterial load (MBL) assay, for measuring viable Mycobacterium...
A molecular assay to quantify Mycobacterium tuberculosis is described. In vitro, 98% (n = 96) of spu...
Molecular bacterial load assay (MBLA) rapidly quantifies viable Mycobacterium tuberculosis (Mtb) and...
A molecular assay to quantify Mycobacterium tuberculosis is described. In vitro, 98% (n = 96) of spu...
Tuberculosis is a difficult disease to treat, a process made more harder as tools to monitor treatme...
Tuberculosis is a difficult disease to treat, a process made more harder as tools to monitor treatme...
In this comparative biomarker study, we analysed 1768 serial sputum samples from 178 patients at 4 s...
In this comparative biomarker study, we analysed 1768 serial sputum samples from 178 patients at 4 s...
The molecular bacterial load (MBL) assay is a new tuberculosis biomarker which provides results in ∼...
The lack of rapid, sensitive, and deployable tuberculosis diagnostic tools is hampering the early di...
This work was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP)...
The early bactericidal activity of antituberculosis agents is usually determined by measuring the re...
This work was supported by the commonwealth studentship award for Bariki Mtafya at University of St ...
Bacterial killing in patients with tuberculosis (TB) relapse was compared to that in patients achiev...
Tuberculosis is caused by Mycobacterium tuberculosis (Mtb), a pathogen classified by the United Nati...